• Product NameArtesunate
• Brief DescriptionInhibitors
• Purification99.14%
• Biological ActivityArtesunate is a part of the artemisinin group of agents with an IC50 of < 5 μM for small cell lung carcinoma cell line H69. Artesunate is a semi-synthetic derivative of artemisinin that is water-soluble and may therefore be given by injection. Artesunate is used primarily as treatment for malaria; but artesunate has also been shown to be >90% efficacious at reducing egg production in Schistosoma haematobium infection.
• Target NameSTAT inhibitor
• CAS No. 88495-63-0
• Calculated MW 384.42
• Formulation C19H28O8
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Nervous system
  SMILES:C[C@@H]1CC[C@H]2[C@H]([C@H](O[C@H]3[C@@]24[C@H]1CCC(O3)(OO4)C)OC(=O)CCC(=O)O)C
  Pathways:JAK/STAT signaling; Stem Cells
  Receptor:STAT
  Boling pt:502.1C
  Melting pt:132-135C
  Solubility:Ethanol: 77 mg/mL (200.3 mM); DMSO: 77 mg/mL (200.3 mM)
  Appearance:White Powder
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1. Cui C, et al. Int Immunopharmacol. 2015 Jul;27(1):110-21.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting